203 related articles for article (PubMed ID: 9973286)
1. Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.
Crawford DC; Meadows KL; Newman JL; Taft LF; Pettay DL; Gold LB; Hersey SJ; Hinkle EF; Stanfield ML; Holmgreen P; Yeargin-Allsopp M; Boyle C; Sherman SL
Am J Hum Genet; 1999 Feb; 64(2):495-507. PubMed ID: 9973286
[TBL] [Abstract][Full Text] [Related]
2. The influence of expanded unmethylated alleles for FRAXA/FRAXE loci in the intellectual performance among Brazilian mentally impaired males.
Barros Santos C; Gonçalves Pimentel MM
Int J Mol Med; 2003 Sep; 12(3):385-9. PubMed ID: 12883656
[TBL] [Abstract][Full Text] [Related]
3. Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.
Patsalis PC; Sismani C; Hettinger JA; Boumba I; Georgiou I; Stylianidou G; Anastasiadou V; Koukoulli R; Pagoulatos G; Syrrou M
Am J Med Genet; 1999 May; 84(3):184-90. PubMed ID: 10331587
[TBL] [Abstract][Full Text] [Related]
4. FRAXA and FRAXE: the results of a five year survey.
Youings SA; Murray A; Dennis N; Ennis S; Lewis C; McKechnie N; Pound M; Sharrock A; Jacobs P
J Med Genet; 2000 Jun; 37(6):415-21. PubMed ID: 10851251
[TBL] [Abstract][Full Text] [Related]
5. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers.
Murray A; Youings S; Dennis N; Latsky L; Linehan P; McKechnie N; Macpherson J; Pound M; Jacobs P
Hum Mol Genet; 1996 Jun; 5(6):727-35. PubMed ID: 8776586
[TBL] [Abstract][Full Text] [Related]
6. Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population.
Meadows KL; Pettay D; Newman J; Hersey J; Ashley AE; Sherman SL
Am J Med Genet; 1996 Aug; 64(2):428-33. PubMed ID: 8844098
[TBL] [Abstract][Full Text] [Related]
7. The role of size, sequence and haplotype in the stability of FRAXA and FRAXE alleles during transmission.
Murray A; Macpherson JN; Pound MC; Sharrock A; Youings SA; Dennis NR; McKechnie N; Linehan P; Morton NE; Jacobs PA
Hum Mol Genet; 1997 Feb; 6(2):173-84. PubMed ID: 9063737
[TBL] [Abstract][Full Text] [Related]
8. A survey of FRAXE allele sizes in three populations.
Zhong N; Ju W; Curley D; Wang D; Pietrofesa J; Wu G; Shen Y; Pang C; Poon P; Liu X; Gou S; Kajanoja E; Ryynänen M; Dobkin C; Brown WT
Am J Med Genet; 1996 Aug; 64(2):415-9. PubMed ID: 8844095
[TBL] [Abstract][Full Text] [Related]
9. DNA diagnosis of FRAXA and FRAXE in Chinese children with neurodevelopmental disorders and fragile X syndrome.
Chan SY; Wong V
Clin Genet; 1998 Mar; 53(3):179-83. PubMed ID: 9630071
[TBL] [Abstract][Full Text] [Related]
10. A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom.
Knight SJ; Ritchie RJ; Chakrabarti L; Cross G; Taylor GR; Mueller RF; Hurst J; Paterson J; Yates JR; Dow DJ; Davies KE
Am J Hum Genet; 1996 May; 58(5):906-13. PubMed ID: 8651274
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of the fragile X syndrome in Yugoslav patients with non-specific mental retardation.
Major T; Culjkovic B; Stojkovic O; Gucscekic M; Lakic A; Romac S
J Neurogenet; 2003; 17(2-3):223-30. PubMed ID: 14668200
[TBL] [Abstract][Full Text] [Related]
12. Screening for fragile X syndrome: results from a school for mentally retarded children.
Hećimović S; Tarnik IP; Barić I; Cakarun Z; Pavelić K
Acta Paediatr; 2002; 91(5):535-9. PubMed ID: 12113322
[TBL] [Abstract][Full Text] [Related]
13. Intermediate alleles at the FRAXA and FRAXE loci in Parkinson's disease.
Costa A; Gao L; Carrillo F; Cáceres-Redondo MT; Carballo M; Díaz-Martín J; Gómez-Garre P; Sobrino F; Lucas M; López-Barneo J; Mir P; Pintado E
Parkinsonism Relat Disord; 2011 May; 17(4):281-4. PubMed ID: 21257332
[TBL] [Abstract][Full Text] [Related]
14. Frequency of FMR1 premutations in a consecutive newborn population by PCR screening of Guthrie blood spots.
Dawson AJ; Chodirker BN; Chudley AE
Biochem Mol Med; 1995 Oct; 56(1):63-9. PubMed ID: 8593539
[TBL] [Abstract][Full Text] [Related]
15. An assessment of screening strategies for fragile X syndrome in the UK.
Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
[TBL] [Abstract][Full Text] [Related]
16. FRAXA and FRAXE prevalence in patients with nonspecific mental retardation in the Hellenic population.
Syrrou M; Georgiou I; Grigoriadou M; Petersen MB; Kitsiou S; Pagoulatos G; Patsalis PC
Genet Epidemiol; 1998; 15(1):103-9. PubMed ID: 9523214
[TBL] [Abstract][Full Text] [Related]
17. Studies of FRAXA and FRAXE in women with premature ovarian failure.
Murray A; Webb J; Grimley S; Conway G; Jacobs P
J Med Genet; 1998 Aug; 35(8):637-40. PubMed ID: 9719368
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the fragile X syndrome in African-Americans.
Crawford DC; Meadows KL; Newman JL; Taft LF; Scott E; Leslie M; Shubek L; Holmgreen P; Yeargin-Allsopp M; Boyle C; Sherman SL
Am J Med Genet; 2002 Jul; 110(3):226-33. PubMed ID: 12116230
[TBL] [Abstract][Full Text] [Related]
19. Instability of the FMR2 trinucleotide repeat region associated with expanded FMR1 alleles.
Brown TC; Tarleton JC; Go RC; Longshore JW; Descartes M
Am J Med Genet; 1997 Dec; 73(4):447-55. PubMed ID: 9415473
[TBL] [Abstract][Full Text] [Related]
20. A simple multiplex FRAXA, FRAXE, and FRAXF PCR assay convenient for wide screening programs.
Strelnikov V; Nemtsova M; Chesnokova G; Kuleshov N; Zaletayev D
Hum Mutat; 1999; 13(2):166-9. PubMed ID: 10094554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
